Supplementary Table 2.
The Gleason score of the patients with different prostate-specific antigen ranges
| PSA ranges | GS <7 | GS ≥7 (HGPCa) | all PCa | HGPCa% |
|---|---|---|---|---|
| Below 4.0 ng ml−1 | 18 | 30 | 48 | 62.5 |
| 4.0–10.0 ng ml−1 | 155 | 296 | 451 | 65.6 |
| 10.0–20.0 ng ml−1 | 138 | 391 | 529 | 73.9 |
| Above 20.0 ng ml−1 | 121 | 865 | 986 | 87.7 |
| The whole cohort | 432 | 1582 | 2014 | 78.6 |
PSA: prostate-specific antigen; GS: Gleason score; PCa: prostate cancer; HGPCa: high-grade prostate cancer